PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
associated with 7 other trademarks
Pharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders

Words that describe this trademark:

central nervous system  pharmaceutical preparations  nervous system  cancer diabetes  products treatment  diabetes central  treatment cancer  system  preparations  autoimmune 

Serial Number:

87503353

Mark:

PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY

Status:

Abandoned-No Statement of Use filed

Status Date:

02-15-2021

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders

Mark Description:

The mark consists of four circles connected by short lines in a manner of a molecular model, all inside of a larger circle and stacked on top of the word "PLEXXIKON", with the words "SCAFFOLD-BASED DRUG DISCOVERY" underneath all.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-14-2017

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

02-15-2021

Business Name:

SHEPPARD MULLIN RICHTER & HAMPTON LLP

Correspondent Name:

Recent Trademark filings by this company